• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Good gene hunting: commercializing safety and efficacy of home genetic test kits.

作者信息

Stevenson M

出版信息

J Biolaw Bus. 1999;3(1):29-39.

PMID:11933969
Abstract

The rapid advancement of genetic identification as a means of diagnosing or identifying the existence of a genetic trait for preventative and reproductive concerns should compel legal experts to determine whether there is sufficient safety and efficacy in genetic tests. Genetic testing has been used by physicians for a number of years to enhance their allopathic practice. Specifically, genetic tests are now being considered as aids in understanding the development and proliferation of certain diseases in society as a whole, and in specific ethnic and familial groups. The purposes of this paper are to: (1) articulate what genetic testing offers, by way of definition and scope; (2) identify statutory and regulatory limitations on the development, distribution, and use of genetic tests; and (3) consider whether the potential availability of home genetic tests should be made accessible to the American public. This paper will further provide a proposed regulation to encourage the development and distribution of home genetic tests.

摘要

相似文献

1
Good gene hunting: commercializing safety and efficacy of home genetic test kits.
J Biolaw Bus. 1999;3(1):29-39.
2
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
3
Truth in testing laws: a shot in the arm for designer gene tests.检测法律中的真相:对设计基因检测的一针强心剂。
Health Matrix Clevel. 2006 Summer;16(2):797-829.
4
Baby doe redux? The Department of Health and Human Services and the Born-Alive Infants Protection Act of 2002: a cautionary note on normative neonatal practice.“婴儿多伊”事件重演?美国卫生与公众服务部及2002年《出生时存活婴儿保护法》:关于规范新生儿医疗行为的警示
Pediatrics. 2005 Oct;116(4):e576-85. doi: 10.1542/peds.2005-1590.
5
The regulation of home diagnostic tests for genetic disorders: can the FDA deny a premarket application on the basis of the device's social impacts?遗传性疾病家用诊断测试的监管:美国食品药品监督管理局能否基于设备的社会影响拒绝上市前申请?
J Biolaw Bus. 2002;5(1):34-43.
6
Separating predictive genetic testing from snake oil: regulation, liabilities, and lost opportunities.区分预测性基因检测与万灵药:监管、责任与错失的机遇。
Jurimetrics. 2000 Fall;41(1):23-52.
7
Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.转基因植物及其衍生食品和饲料的安全性与营养评估:动物饲养试验的作用
Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13.
8
Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.基因检测服务的商业化:美国食品药品监督管理局、市场力量与生物塔罗牌
Tulane Law Rev. 1997 Mar;71(4):1211-312.
9
[Diagnostic kits in parasitology: which controls?].[寄生虫学诊断试剂盒:哪些对照?]
Parassitologia. 2004 Jun;46(1-2):145-9.
10
Commercial molecular diagnostics in the U.S.: The Human Genome Project to the clinical laboratory.美国的商业分子诊断:从人类基因组计划到临床实验室。
Hum Mutat. 2002 Apr;19(4):324-33. doi: 10.1002/humu.10061.